High-Throughput Screening Techniques

The use of laboratory animals has been the ‘standard’ procedure for the dermal safety and efficacy evaluation of consumer, chemical and/or pharmaceutical products for many decades. However, both scientific and ethical considerations have driven the development of alternative methods aiming to reduce, replace and refine animal experimentation (Russell WMS, Burch RL, Hume CW. The principles of humane experimental technique. 1959). Especially, human tissue-engineered skin models demonstrate to be very valuable alternatives for dermal toxicity and efficacy testing. Since human skin models are available in quality ensured commercial companies, they are routinely used by industry for in-house screening and more recently also for regulatory toxicity testing applications. Whereas today only skin corrosion and skin irritation test methods are listed in regulatory guidelines, many new non-animal tissue-based dermal toxicity testing applications are currently in development and validation, including skin sensitization, genotoxicity and phototoxicity. In addition, the adoption of skin model-based tests in regulatory guidelines has stimulated regulatory bodies in other parts of the world such as Brazil, China, India and South Korea to harmonize with the global trend to accept validated alternative methods, indicating that the demand for skin models in the future will be largely increased. To ensure the availability of high-quality skin models in very large quantities, automated production is the ultimate solution. Although the field of high-throughput testing has expanded massively over the last years in pharmacological research, it is rarely used in the assessment of adverse health effects. The reason for that might be the higher complexity of three-dimensional (3D) reconstructed tissues employed in toxicology compared to two-dimensional (2D) systems routinely used for drug discovery applications. Furthermore, there is a lack for standardized test methods that can be implemented in a high-throughput approach. This chapter will focus on new production technologies to generate skin models in sufficient numbers and emerging nondestructive methods to assess tissues.

[1]  K. König,et al.  Two-photon microscopes and in vivo multiphoton tomographs--powerful diagnostic tools for tissue engineering and drug delivery. , 2006, Advanced drug delivery reviews.

[2]  Niamh Plunkett,et al.  Bioreactors in tissue engineering. , 2011, Technology and health care : official journal of the European Society for Engineering and Medicine.

[3]  Efstratios N. Pistikopoulos,et al.  Global superstructure optimisation of red blood cell production in a parallelised hollow fibre bioreactor , 2014, Comput. Chem. Eng..

[4]  Jose Cotovio,et al.  The In Vitro Acute Skin Irritation of Chemicals: Optimisation of the EPISKIN Prediction Model within the Framework of the ECVAM Validation Process , 2005, Alternatives to laboratory animals : ATLA.

[5]  P. Lister The role of pharmacodynamic research in the assessment and development of new antibacterial drugs. , 2006, Biochemical pharmacology.

[6]  J. Bailar,et al.  Toxicity Testing in the 21st Century: A Vision and a Strategy , 2010, Journal of toxicology and environmental health. Part B, Critical reviews.

[7]  Laurent Griscom,et al.  Behavior of HepG2/C3A cell cultures in a microfluidic bioreactor , 2011 .

[8]  J Mark Meacham,et al.  Physical Methods for Intracellular Delivery , 2014, Journal of laboratory automation.

[9]  M. Leist,et al.  Ex vivo culture of intestinal crypt organoids as a model system for assessing cell death induction in intestinal epithelial cells and enteropathy , 2014, Cell Death and Disease.

[10]  Ludovic Vallier,et al.  Maturation of Induced Pluripotent Stem Cell Derived Hepatocytes by 3D-Culture , 2014, PloS one.

[11]  Jeffrey T Borenstein,et al.  Approaches to in vitro tissue regeneration with application for human disease modeling and drug development. , 2014, Drug discovery today.

[12]  Ali Khademhosseini,et al.  Organ-on-a-chip platforms for studying drug delivery systems. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[13]  D. Ingber,et al.  Microfluidic organs-on-chips , 2014, Nature Biotechnology.

[14]  Gary J. Lye,et al.  Impact of aeration strategies on fed-batch cell culture kinetics in a single-use 24-well miniature bioreactor , 2014 .

[15]  D. Wendt,et al.  The role of bioreactors in tissue engineering. , 2004, Trends in biotechnology.

[16]  Yoshitake Yamamoto,et al.  Analysis for the change of skin impedance , 1977, Medical and Biological Engineering and Computing.

[17]  Ken E. Whelan,et al.  The Automation of Science , 2009, Science.

[18]  S. Giselbrecht,et al.  Differences in morphogenesis of 3D cultured primary human osteoblasts under static and microfluidic growth conditions. , 2014, Biomaterials.

[19]  Steven Boyce,et al.  Assessment of an automated bioreactor to propagate and harvest keratinocytes for fabrication of engineered skin substitutes. , 2007, Tissue engineering.

[20]  Kenneth M. Yamada,et al.  Taking Cell-Matrix Adhesions to the Third Dimension , 2001, Science.

[21]  J. Mansbridge Commercial considerations in tissue engineering , 2006, Journal of anatomy.

[22]  Sandra Coecke,et al.  Automation of an in vitro cytotoxicity assay used to estimate starting doses in acute oral systemic toxicity tests. , 2012, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[23]  M. Hérin,et al.  A simple reconstructed human epidermis: preparation of the culture model and utilization in in vitro studies , 2004, Archives of Dermatological Research.

[24]  Maria Dimaki,et al.  Microfluidic bioreactors for culture of non-adherent cells , 2011 .

[25]  A. Bowcock,et al.  Getting under the skin: the immunogenetics of psoriasis , 2005, Nature Reviews Immunology.

[26]  Teruo Fujii,et al.  Microfluidic PDMS (Polydimethylsiloxane) Bioreactor for Large‐Scale Culture of Hepatocytes , 2004, Biotechnology progress.

[27]  H. Walles,et al.  A bioreactor system for interfacial culture and physiological perfusion of vascularized tissue equivalents. , 2013, Biotechnology journal.

[28]  Ashraf Amanullah,et al.  Novel micro‐bioreactor high throughput technology for cell culture process development: Reproducibility and scalability assessment of fed‐batch CHO cultures , 2010, Biotechnology and bioengineering.

[29]  Charles W. Schmidt,et al.  TOX 21: New Dimensions of Toxicity Testing , 2009, Environmental health perspectives.

[30]  R Radhakrishnan,et al.  High-Throughput Screening: The Hits and Leads of Drug Discovery- An Overview , 2011 .

[31]  Jens Eickhoff,et al.  In vivo multiphoton fluorescence lifetime imaging of protein-bound and free nicotinamide adenine dinucleotide in normal and precancerous epithelia. , 2007, Journal of biomedical optics.

[32]  Mayasari Lim,et al.  Stem cell bioprocessing: fundamentals and principles , 2009, Journal of The Royal Society Interface.

[33]  R. Subramanian,et al.  Biosynthesis of Drug Metabolites Using Microbes in Hollow Fiber Cartridge Reactors: Case Study of Diclofenac Metabolism by Actinoplanes Species , 2008, Drug Metabolism and Disposition.

[34]  Uwe Marx,et al.  ‘Human-on-a-chip’ Developments: A Translational Cutting-edge Alternative to Systemic Safety Assessment and Efficiency Evaluation of Substances in Laboratory Animals and Man? , 2012, Alternatives to laboratory animals : ATLA.

[35]  M. Rimann,et al.  Automation of 3D Cell Culture Using Chemically Defined Hydrogels , 2014, Journal of laboratory automation.

[36]  John E. Hambor,et al.  Bioreactor Design and Bioprocess Controls for Industrialized Cell Processing Bioengineering Strategies and Platform Technologies , 2012 .

[37]  Jennifer Southgate,et al.  Biomimetic urothelial tissue models for the in vitro evaluation of barrier physiology and bladder drug efficacy. , 2014, Molecular pharmaceutics.

[38]  Natalia Kuzmina,et al.  Electrical impedance as a potential tool to distinguish between allergic and irritant contact dermatitis. , 2003, Journal of the American Academy of Dermatology.

[39]  R. Norton,et al.  Enhancing the Buccal Mucosal Delivery of Peptide and Protein Therapeutics , 2014, Pharmaceutical Research.

[40]  Ruili Huang,et al.  Compound Cytotoxicity Profiling Using Quantitative High-Throughput Screening , 2007, Environmental health perspectives.

[41]  J. Malda,et al.  Functional and phenotypic characterization of human keratinocytes expanded in microcarrier culture. , 2009, Journal of biomedical materials research. Part A.

[42]  Ruili Huang,et al.  The future of toxicity testing: a focus on in vitro methods using a quantitative high-throughput screening platform. , 2010, Drug discovery today.

[43]  T. Byzova,et al.  Angiogenesis in melanoma. , 2007, Seminars in oncology.

[44]  V. Rogiers,et al.  Practical Problems Encountered during the Cultivation of an Open-Source Reconstructed Human Epidermis Model on a Polycarbonate Membrane and Protein Quantification , 2013, Skin Pharmacology and Physiology.

[45]  John A. Williams,et al.  Keys to bioreactor selections , 2002 .

[46]  Alessandro Tocchio,et al.  Versatile fabrication of vascularizable scaffolds for large tissue engineering in bioreactor. , 2015, Biomaterials.

[47]  R. Vreeken,et al.  Increased presence of monounsaturated fatty acids in the stratum corneum of human skin equivalents. , 2013, The Journal of investigative dermatology.

[48]  Katja Schenke-Layland,et al.  Raman spectroscopy for the non‐contact and non‐destructive monitoring of collagen damage within tissues , 2012, Journal of biophotonics.

[49]  Yan Li,et al.  Stem cell engineering in bioreactors for large‐scale bioprocessing , 2014 .

[50]  Robin A. Felder,et al.  A Review of Cell Culture Automation , 2002 .

[51]  J. Hansmann,et al.  Impedance Spectroscopy for the Non-Destructive Evaluation of In Vitro Epidermal Models , 2014, Pharmaceutical Research.

[52]  Karsten König,et al.  Impact of cryopreservation on extracellular matrix structures of heart valve leaflets. , 2006, The Annals of thoracic surgery.

[53]  V. Centonze,et al.  Multiphoton excitation provides optical sections from deeper within scattering specimens than confocal imaging. , 1998, Biophysical journal.

[54]  Mandy B. Esch,et al.  How multi-organ microdevices can help foster drug development. , 2014, Advanced drug delivery reviews.

[55]  Heike Walles,et al.  Raman spectroscopy in biomedicine – non-invasive in vitro analysis of cells and extracellular matrix components in tissues , 2012, Biotechnology journal.

[56]  E. Vogler,et al.  In Vitro Mimics of Bone Remodeling and the Vicious Cycle of Cancer in Bone , 2014, Journal of cellular physiology.

[57]  G W Hastings,et al.  Model to characterize strain generated potentials in bone. , 1988, Journal of biomedical engineering.

[58]  Silvia Scaglione,et al.  Mesenchymal stem cell culture in convection-enhanced hollow fibre membrane bioreactors for bone tissue engineering , 2011 .

[59]  Lorenz M Mayr,et al.  Novel trends in high-throughput screening. , 2009, Current opinion in pharmacology.

[60]  N. Kotov,et al.  Three-dimensional cell culture matrices: state of the art. , 2008, Tissue engineering. Part B, Reviews.

[61]  Elmar Heinzle,et al.  3D organotypic cultures of human HepaRG cells: a tool for in vitro toxicity studies. , 2013, Toxicological sciences : an official journal of the Society of Toxicology.

[62]  Manuel J T Carrondo,et al.  Merging bioreactor technology with 3D hepatocyte-fibroblast culturing approaches: Improved in vitro models for toxicological applications. , 2011, Toxicology in vitro : an international journal published in association with BIBRA.

[63]  Katja Schenke-Layland,et al.  Raman spectroscopy: a noninvasive analysis tool for the discrimination of human skin cells. , 2011, Tissue engineering. Part C, Methods.

[64]  Julian Chaudhuri Special Issue: Design of Bioreactor Systems for Tissue Engineering , 2015 .

[65]  Barry Cense,et al.  Advances in optical coherence tomography imaging for dermatology. , 2004, The Journal of investigative dermatology.

[66]  Adam Smith,et al.  Screening for drug discovery: The leading question , 2002, Nature.

[67]  H. Wenck,et al.  A novel treatment option for photoaged skin , 2008, Journal of cosmetic dermatology.

[68]  Lorenz M Mayr,et al.  The Future of High-Throughput Screening , 2008, Journal of biomolecular screening.

[69]  Florian Groeber,et al.  Bioreactors in tissue engineering—principles, applications and commercial constraints , 2013, Biotechnology journal.

[70]  Michel Manfait,et al.  Molecular characterization of reconstructed skin model by Raman microspectroscopy: comparison with excised human skin. , 2007, Biopolymers.

[71]  S A Sundberg,et al.  High-throughput and ultra-high-throughput screening: solution- and cell-based approaches. , 2000, Current opinion in biotechnology.

[72]  T J Spencer,et al.  In silico multi‐scale model of transport and dynamic seeding in a bone tissue engineering perfusion bioreactor , 2013, Biotechnology and bioengineering.